Investigation of the effectiveness of lacosamide in generalized seizures.
Phase 3
- Conditions
- Generalized tonic-clonic seizures..Epilepsy and recurrent seizures
- Registration Number
- IRCT20220524054982N1
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Having generalized tonic-clonic seizures
Over eighteen years of age
Consent to participate in the study
Not taking multiple anticonvulsants at the same time
Exclusion Criteria
Willingness of patients to withdraw from the study
-
Having a chronic disease that interferes with the evaluation of the patient
Having heart diseases
pregnancy
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Tonic-clonic seizure. Timepoint: On the first day and three months later and six months after starting the drug. Method of measurement: EEG device and patient bedside.
- Secondary Outcome Measures
Name Time Method